Dalrada Corporation told shareholders that company director Harvey Hershkowitz has been appointed as President of its rapidly expanding subsidiary Dalrada Health.
Hershkowitz's career in the healthcare industry spans over 35 years, during which he has served as chairman of many boards. “This broad perspective provides Dalrada Health with a significant advantage in implementing its current initiatives and expanding its capabilities,” said the company.
In a statement, Dalrada CEO and Chairman Brian Bonar said: "Given the growth and expansion of our healthcare division, we are bringing Harvey on as a seasoned executive to drive focus, execution, and results.”
READ: Dalrada sees FY1Q revenue soar 506% as its health and technology units generate rapid growth
“His motivation for furthering the healthcare industry aligns with and empowers Dalrada's global vision and its business expansion implementation strategy," he added.
Hershkowitz has vast experience with acute care hospitals, skilled nursing facilities, major physician groups, biosciences, pharmaceutical and healthcare.
"Dalrada continues to exceed expectations, and I am excited to help achieve our future goals. As a publicly-traded company with more than ten products and services, Dalrada serves the top growing industries, and we are looking forward to making our impact known," said Hershkowitz.
Dalrada Health's business segments are GlanHealth, cerVIA, Empower Genomics, Pala Diagnostics, new acquisition International Health Group (IHG), and Sòlas Rejuvenation + Wellness.
The company highlighted Dalrada Health’s milestones this year which include Chief Medical Officer Dr. Payal Keswarpu sharing cerVIA clinical study results at the 17th World Congress for Cervical Pathology and Colposcopy in support of the world's cervical cancer elimination initiative.
Dalrada Health has launched coronavirus (COVID-19) onsite testing with Pala Diagnostics and Empower Genomics. The diversified group also grew GlanHealth’s alcohol-free sanitizing line, including hand sanitizers, surface cleaners, electrostatic sprayers, and bulk sanitizers.
Meanwhile, Sòlas Rejuvenation + Wellness announced its flagship location with advanced medical-driven therapies and traditional wellness spa services.
Trends in the healthcare industry reflect the growing acceptance and adoption of technology-driven informatics, telemedicine and remote patient monitoring.
"COVID-19 brought profound changes to the healthcare industry, and standard health care checkups and general health took a back seat. With these drastic shifts in the industry, we are committed to offering innovation with the right solutions to keep people healthy," said Hershkowitz.
From 2021, the global healthcare services market is expected to grow at a compound annual growth rate (CAGR) of 7% to touch $9725.4 billion in 2023, according to The Business Research Company. Significantly, alongside renewable "clean" energy and IT, healthcare is positioned as one of the three largest growing industries over the next 10 years.
Contact the author Uttara Choudhury at uttara@proactiveinvestors.com
Follow her on Twitter: @UttaraProactive